Breakthrough in Cancer Gene Therapy: Nanoparticles Hold the Key

Researchers at the Institute of Medicinal Biotechnology have made significant advancements in the field of cancer gene therapy, utilizing nanoparticles to deliver therapeutic agents directly to cancer cells. This innovative approach has shown promise in addressing genetic skin disorders and cancers, offering localized treatment with enhanced bioavailability and reduced systemic side effects. The study, supported by the European Union-NextGenerationEU program and the European Union (EU), has revealed the potential of nanoparticles in tumor growth inhibition, immune modulation, and gene correction.

Key Takeaways:

• The stratum corneum presents a formidable barrier to the delivery of nucleic acids, hindering the effectiveness of traditional gene therapy approaches.
• Recent innovations in nanoparticle technologies, such as cationic liposomes and polymer-based carriers, have overcome these challenges by enhancing penetration, stability, and target specificity.
• Techniques like microneedles and iontophoretic applications further facilitate effective delivery into skin layers, while advanced formulations combining nanoparticles with therapeutic agents demonstrate significant potential in tumor growth inhibition and gene correction.
• Artificial intelligence (AI) is being integrated into nanoparticle design and delivery systems to refine transdermal delivery technologies, advancing precision medicine in dermatological applications and cancer therapy.
• The challenges of immunogenicity and systemic degradation persist, but emerging technologies are working to address these issues.
• The study has been peer-reviewed and published in Current Opinion In Biomedical Engineering.

Statistics:

• The study was supported by the European Union-NextGenerationEU program and the European Union (EU).
• The research was conducted by researchers at the Institute of Medicinal Biotechnology, including Mohammad Amin Moosavi, Fatemeh Mokhles, Juan Gonzalez-Valdivieso, and Marco Cordani.
• The study aimed to develop novel approaches for the delivery of nucleic acids, with a focus on cancer gene therapy and skin diseases.
• The researchers employed advanced nanoparticle technologies to enhance delivery efficiency, stability, and target specificity.

Sources:

• NewsRx. New Cancer Gene Therapy Study Findings Recently Were Reported by Researchers at Institute of Medicinal Biotechnology (Advances In Nanoparticle-mediated Transdermal Delivery of Nucleic Acids As Therapy of Skin Disorders and Cancer). Cancer Weekly. September 23, 2025; p 44.
• European Union-NextGenerationEU program.
• European Union (EU).
• Institute of Medicinal Biotechnology (IMB).